Efficacy of Compound Kushen Injection in Relieving Cancer-Related Pain: A Systematic Review and Meta-Analysis

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Guo, Yu Ming ^a   Huang, Yi Xue ^a   Shen, Hong Hui ^a   Sang, Xiu Xiu ^a   Ma, Xiao ^a   Zhao, Yan Ling ^a   Xiao, Xiao He ^a  

^a 302 MILITARY HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CHINESE DRUG; KUSHEN; UNCLASSIFIED DRUG;

ALOPECIA; ANALGESIA; ANALGESIC ACTIVITY; BONE MARROW DEPRESSION; CANCER PAIN; CHINESE MEDICINE; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; INJECTION; KARNOFSKY PERFORMANCE STATUS; LEUKOPENIA; LIVER INJURY; META ANALYSIS; NEPHROTOXICITY; OUTCOME ASSESSMENT; PAIN INTENSITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE;

EID: 84945548191     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/840742     Document Type: Review

References (30)

1. S. C. McMillan, M. Tittle, S. Hagan, and J. Laughlin, "Management of pain and pain-related symptoms in hospitalized veterans with cancer," Cancer Nursing, vol. 23, no. 5, pp. 327-336, 2000.
2. D. Carr, L. Goudas, D. Lawrence et al., "Management of cancer symptoms: pain, depression, and fatigue," Evidence Report/Technology Assessment (Summary), no. 61, pp. 1-5, 2002.
3. N. Wells, "Pain intensity and pain interference in hospitalized patients with cancer," Oncology Nursing Forum, vol. 27, no. 6, pp. 985-991, 2000.
4. E. Ernst and B. R. Cassileth, "The prevalence of complementary/ alternative medicine in cancer: a systematic review," Cancer, vol. 83, no. 4, pp. 777-782, 1998.
5. M. A. Richardson, T. Sanders, J. L. Palmer, A. Greisinger, and S. E. Singletary, "Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology," Journal of Clinical Oncology, vol. 18, no. 13, pp. 2505-2514, 2000.
6. J. Tian, W.-H. Wang, H.-M. Cao, and Z.-M. Wang, "Determination of matrine, sophoridine and oxymatrine in compound Kushen injection by HPLC," Zhongguo Zhongyao Zazhi, vol. 32, no. 3, pp. 222-224, 2007.
7. Z. Zhao, H. Fan, T. Higgins et al., "Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways," Cancer Letters, vol. 355, no. 2, pp. 232-241, 2014.
8. C. Liang, G. Yanwei, W. Zhiwei et al., "Clinical observation of compoundKusheninjection combinedwithTACE in treatment of liver cancer," Clinical Chinese Journal of Information on TCM, vol. 21, no. 6, pp. 98-99, 2014.
9. D. Li, L. Zhuangwei, W. Yiting et al., "Efficacy of compound kushen injection by continuously intravenous infusion combined with TACE in treating middle-and-late stage primary liver cancer," in Proceedings of the China Cancer Academic Conference 2008 of TCM&National TCM Academic Conference of Famous Doctors, pp. 118-120, Beijing, China, 2008.
10. D. Li, L. Zhuangwei, W. Yiting et al., "Effect ofmatrine injections continuous infusion combined TACE treatment 30 cases with advanced liver cancer," Journal of Practical Traditional Chinese Internal Medicine, vol. 24, no. 11, pp. 22-24, 2010.
11. F. Jianwei, D. Yuan, and H. Wei, "Clinical observation on healing 40 cases advanced stage 14 gastric cancer with composite kushen injection and chemotherapy," Journal of Emergency in Traditional Chinese Medicine, vol. 20, no. 1, pp. 152-153, 2011.
12. G. Jianlin, L. Hong, and W. Liping, "Clinical observation on healing 63 case advanced stage NSCLC with composite kusheng injection and NP program," Journal of XinJiangMedical University, vol. 29, no. 9, pp. 1018-1019, 2007.
13. L. Yihang and L. Yinghui, "Clinical observation of gastric cancer treated by chemotherapy combined with Yanshu injection," Jilin Medical Journal, vol. 31, no. 30, p. 5332, 2011.
14. L. Yanru, "Research on non-small cell lung cancer treating with compound kushen injection and thermotherapy," Chinese Journal ofModernDrugApplication, vol. 7, no. 6, pp. 71-72, 2013.
15. S. Jing and Y. Liping, "Clinical observation on late stage lung cancer treating with chemotherapy and compound kushen injection," Traditional Chinese medicine in Inner Mongolia, vol. 11, pp. 13-14, 2012.
16. S. Xinwen, "Addition of compound Kushen injection to vinorelbine plus cisplatin for patients with nonsmall cell lung cancer clinical observation," Evaluation and Analysis of Drug-Use in Hospitals of China, vol. 12, no. 7, pp. 645-648, 2012.
17. W. Huijuan, Z. Hongzhi, and L. Tao, "Clinical observation of late nonsmall-cell lung cancer treated by chemotherapy combined with yanshu injection," Evaluation and Analysis of Drug-Use in Hospitals of China, vol. 6, no. 1, pp. 43-45, 2006.
18. W. Shuo, L. Hongsheng, Z. Xinwen et al., "A randomized and multicenter clinical trial of compound matrine injection combined with hepatic artery interventional therapy in treatment of primary liver cancer," Chinese Journal of Clinical Oncology and Rehabilitation, vol. 21, no. 3, pp. 331-335, 2014.
19. X. Jinxiu, Z. Shiye, W. Airong et al., "Clinical observation of compound Kushen injection combined with FOLFOX regimen in treatment of advanced gastric cancer," Chinese Archives of Traditional Chinese Medicine, vol. 31, no. 8, pp. 1812-1815, 2013.
20. X. Xiaodong, Z. Zhendong, L. Dawei et al., "Clinical observation on improving the quality of life on late stage of colorectal carcinoma with compound matrine injections," in Proceedings of the 10th National Combine Traditional Chinese and Western Medicine Tumor Academic Conference, pp. 294-296, Shenyang, China, 2006.
21. Y. Jie, C. Xiang, Z. Xiaobing et al., "Clinical observation of colorectal cancer treating with compound kushen injection and chemotherapy," Medical Recapitula, vol. 13, no. 23, pp. 1872-1874, 2007.
22. Y. Zhengang and W. Bingzhe, "Efficacy of large dose of compound matrine injection combined chemotherapy for nonsmall- cell lung cancer," Evaluation and Analysis of Drug-Use in Hospitals of China, vol. 12, no. 2, pp. 149-152, 2012.
23. Z. Jincao and S. Peng, "Clinical study on com pound Sophora flavescens Ait com bined with chemotherapy for colorectal - cancer," Journal of Clinical Medicine in Practice, vol. 16, no. 11, pp. 101-103, 2012.
24. M. S. Walid, S. N. Donahue, D. M. Darmohray et al., "The fifth vital sign - what does it mean?" Pain Practice, vol. 8, no. 6, pp. 417-422, 2008.
25. P. Sloan and R. Melzack, "Long-term patterns of morphine dosage and pain intensity among cancer patients," The Hospice Journal, vol. 14, no. 2, pp. 35-47, 1999.
26. B. Cassileth, C. Trevisan, and J. Gubili, "Complementary therapies for cancer pain," Current Pain and Headache Reports, vol. 11, no. 4, pp. 265-269, 2007.
27. W. Wang, R. L. You, W. J. Qin et al., "Anti-tumor activities of active ingredients in Compound Kushen Injection," Acta Pharmacologica Sinica, vol. 36, no. 6, pp. 676-679, 2015.
28. B. Yanju, L. Yang, B. Hua et al., "A systematic review and metaanalysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain," Supportive Care in Cancer, vol. 22, no. 3, pp. 825-836, 2014.
29. Q. Sun, W. Ma, Y. Gao, W. Zheng, B. Zhang, and Y. Peng, "Metaanalysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma," African Journal of Traditional, Complementary, and Alternative Medicines, vol. 9, no. 2, pp. 178-188, 2012.
30. K. F. Schulz, D. G. Altman, D. Moher, and The CONSORT Group, "CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials," PLoSMedicine, vol. 7, no. 3, Article IDe1000251, 2010.